Literature DB >> 12783160

Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation.

Cristiane Ritter1, Michael Andrades, Mário Luis C Frota Júnior, Fernanda Bonatto, Ricardo A Pinho, Manuela Polydoro, Fábio Klamt, Cleovaldo T S Pinheiro, Sérgio S Menna-Barreto, José Cláudio F Moreira, Felipe Dal-Pizzol.   

Abstract

OBJECTIVE: This study assessed parameters of free radical damage to biomolecules, mitochondrial superoxide production, superoxide dismutase, and catalase activities and their relationship to sepsis mortality. DESIGN AND
SETTING: Prospective animal study in a university laboratory for experimental.
SUBJECTS: 140 male Wistar rats.
INTERVENTIONS: The animals were randomly divided into three groups: sham-operated (n=20), cecal ligation and perforation resuscitated with normal saline (n=40), and cecal ligation and perforation with normal saline plus antibiotics (n=40). MEASUREMENTS AND
RESULTS: Blood samples were collected from all animals 3, 12, and 24 h after CLP through a jugular catheter inserted before CLP. Rats were evaluated during 5 days after the intervention. Nonsurvivor animals were grouped according to the duration between sepsis induction and death, and oxidative parameters were compared to survivors and sham-operated. Lipid peroxidation, protein carbonyls, and superoxide dismutase were significantly increased in nonsurvivor septic rats and were predictive of mortality. We demonstrated that there is a different modulation of superoxide dismutase and catalase in nonsurvivors during the course of septic response. There was a marked increase in superoxide dismutase activity without a proportional increase in catalase activity in nonsurvivors.
CONCLUSIONS: This is the first report of plasma superoxide dismutase as an earlier marker of mortality. Ours results might help to clarify an important aspect of oxidative response to sepsis, i.e., an increase in superoxide dismutase activity without a proportional increase in catalase activity

Entities:  

Mesh:

Year:  2003        PMID: 12783160     DOI: 10.1007/s00134-003-1789-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  46 in total

1.  Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs.

Authors:  N C Olson; M K Grizzle; D L Anderson
Journal:  J Appl Physiol (1985)       Date:  1987-10

2.  N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.

Authors:  N Rank; C Michel; C Haertel; A Lenhart; M Welte; A Meier-Hellmann; C Spies
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

3.  Superoxide dismutase in rats with sepsis. Effect on survival rate and amino acid transport.

Authors:  B W Warner; P O Hasselgren; J H James; H Bialkowska; D F Rigel; C Ogle; J E Fischer
Journal:  Arch Surg       Date:  1987-10

4.  Defining the role of oxyradicals in the pathogenesis of sepsis.

Authors:  J J Zimmerman
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

Review 5.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

6.  Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients.

Authors:  C C Winterbourn; I H Buss; T P Chan; L D Plank; M A Clark; J A Windsor
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

7.  Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia.

Authors:  J Boczkowski; C L Lisdero; S Lanone; A Samb; M C Carreras; A Boveris; M Aubier; J J Poderoso
Journal:  FASEB J       Date:  1999-09       Impact factor: 5.191

8.  Prognostic role of antioxidant enzymes in sepsis: preliminary assessment.

Authors:  A Warner; A Bencosme; D Healy; C Verme
Journal:  Clin Chem       Date:  1995-06       Impact factor: 8.327

Review 9.  Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine.

Authors:  Daniela Salvemini; Salvatore Cuzzocrea
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

Review 10.  An overview of mortality risk prediction in sepsis.

Authors:  S L Barriere; S F Lowry
Journal:  Crit Care Med       Date:  1995-02       Impact factor: 7.598

View more
  60 in total

1.  Antioxidant therapy in sepsis.

Authors:  Gerd Albuszies; Uwe Bernd Brückner
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

Review 2.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

3.  Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats.

Authors:  Mágada T Schwalm; Matheus Pasquali; Samantha P Miguel; João Paulo A Dos Santos; Francieli Vuolo; Clarissa M Comim; Fabrícia Petronilho; João Quevedo; Daniel P Gelain; José Cláudio F Moreira; Cristiane Ritter; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

4.  Oxidative stress biomarkers in pediatric sepsis: a prospective observational pilot study.

Authors:  Víctor Molina; Bettina von Dessauer; Ramón Rodrigo; Cristian Carvajal
Journal:  Redox Rep       Date:  2016-10-13       Impact factor: 4.412

5.  Is there a role for high mobility group box 1 and the receptor for advanced glycation end products in the genesis of long-term cognitive impairment in sepsis survivors?

Authors:  Felipe Dal-Pizzol; Matheus Pasquali; João Quevedo; Daniel Pens Gelain; José Cláudio Fonseca Moreira
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

6.  The decrease on Na(+), K(+)-ATPase activity in the cortex, but not in hippocampus, is reverted by antioxidants in an animal model of sepsis.

Authors:  Isabela Casagrande Jeremias; Giselli Scaini; Larissa Constantino; Francieli Vuolo; Andreia Kurek Ferreira; Emilene Barros Silva Scherer; Janaina Kolling; Arethuza da Silva Dornelles; Angela Terezinha de Souza Wyse; Maurício Reis Bogo; Felipe Dal-Pizzol; Emilio Luiz Streck
Journal:  Mol Neurobiol       Date:  2012-07-04       Impact factor: 5.590

7.  Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.

Authors:  Yasmine F Ibrahim; Rabab A Moussa; Asmaa M A Bayoumi; Al-Shaimaa F Ahmed
Journal:  Inflammopharmacology       Date:  2019-08-22       Impact factor: 4.473

8.  CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis.

Authors:  Monique Michels; Lucinéia Gainski Danieslki; Andriele Vieira; Drielly Florentino; Dhébora Dall'Igna; Letícia Galant; Beatriz Sonai; Francieli Vuolo; Franciele Mina; Bruna Pescador; Diogo Dominguini; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

9.  Glycyrrhizic Acid Prevents Sepsis-Induced Acute Lung Injury and Mortality in Rats.

Authors:  Hongyu Zhao; Min Zhao; Yu Wang; Fengchun Li; Zhigang Zhang
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

10.  Effect of SOD-1 over-expression on myocardial function during resuscitated murine septic shock.

Authors:  Katja Baumgart; Vladislava Simkova; Florian Wagner; Sandra Weber; Michael Georgieff; Peter Radermacher; Gerd Albuszies; Eberhard Barth
Journal:  Intensive Care Med       Date:  2008-10-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.